|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.6 TWD | -0.44% |
|
+1.12% | +13.00% |
| Apr. 15 | Orient Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Orient Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Orient Pharma Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 511.86 million compared to TWD 463.34 million a year ago. Net loss was TWD 28.76 million compared to TWD 102.65 million a year ago.
Basic loss per share from continuing operations was TWD 0.15 compared to TWD 0.55 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.00% | 155M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
ORIENT PHARMA CO., LTD. 
